ResearcherParul UniversityNo recent work listed
Shreni Agrawal
Matched on OpenAlex author ID A5011442192.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2023: 2 papers
Papers 2
- Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through computational approach. First author DOI 10.1007/s12032-023-01996-w↗
- Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancreatic cancer through bioinformatics approa… Co-author DOI 10.1007/s13205-023-03570-7↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Richa Das · 2 shared papers, 2023
- Paper Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through c… DOI 10.1007/s12032-023-01996-w↗
- Paper Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancrea… DOI 10.1007/s13205-023-03570-7↗
- Amit Kumar Tripathi · 2 shared papers, 2023
- Paper Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through c… DOI 10.1007/s12032-023-01996-w↗
- Paper Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancrea… DOI 10.1007/s13205-023-03570-7↗
- Kavindra Nath Tiwari · 2 shared papers, 2023
- Paper Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through c… DOI 10.1007/s12032-023-01996-w↗
- Paper Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancrea… DOI 10.1007/s13205-023-03570-7↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.